ABDX vs. AGL, YGEN, PRM, VRCI, GDR, GENI, DMTR, LLAI, LLA, and IDHC
Should you be buying Abingdon Health stock or one of its competitors? The main competitors of Abingdon Health include ANGLE (AGL), Yourgene Health (YGEN), Proteome Sciences (PRM), Verici Dx (VRCI), genedrive (GDR), GENinCode (GENI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.
Abingdon Health vs. Its Competitors
ANGLE (LON:AGL) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.
ANGLE currently has a consensus price target of GBX 40, suggesting a potential upside of 584.93%. Given ANGLE's stronger consensus rating and higher probable upside, research analysts clearly believe ANGLE is more favorable than Abingdon Health.
17.5% of ANGLE shares are owned by institutional investors. Comparatively, 1.9% of Abingdon Health shares are owned by institutional investors. 2.7% of ANGLE shares are owned by company insiders. Comparatively, 10.4% of Abingdon Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.13, suggesting that its stock price is 87% less volatile than the S&P 500.
Abingdon Health has a net margin of -20.72% compared to ANGLE's net margin of -890.91%. Abingdon Health's return on equity of -62.56% beat ANGLE's return on equity.
In the previous week, ANGLE had 2 more articles in the media than Abingdon Health. MarketBeat recorded 2 mentions for ANGLE and 0 mentions for Abingdon Health. ANGLE's average media sentiment score of 0.20 beat Abingdon Health's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.
Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.
Summary
ANGLE beats Abingdon Health on 9 of the 16 factors compared between the two stocks.
Get Abingdon Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABDX and its competitors with MarketBeat's FREE daily newsletter.
Abingdon Health Competitors List
Related Companies and Tools
This page (LON:ABDX) was last updated on 9/8/2025 by MarketBeat.com Staff